Search Results - "Kedar, Amos"

Refine Results
  1. 1

    Ependymoma: results, prognostic factors and treatment recommendations by McLaughlin, M P, Marcus, Jr, R B, Buatti, J M, McCollough, W M, Mickle, J P, Kedar, A, Maria, B L, Million, R R

    “…To review the University of Florida experience in treating ependymomas, analyze prognostic factors, and provide treatment recommendations. Forty-one patients…”
    Get more information
    Journal Article
  2. 2

    Acupuncture for cancer patients by Kedar, Amos, Hakimian, Aliza, Gamus, Dorit

    Published in Progress in palliative care (01-11-2012)
    “…This article presents key studies on the use of acupuncture in the management of different adverse reactions to cancer treatments. Acupuncture should be…”
    Get full text
    Journal Article
  3. 3

    Outcome after radiotherapy of primary spinal cord glial tumors by McLaughlin, M P, Buatti, J M, Marcus, Jr, R B, Maria, B L, Mickle, P J, Kedar, A

    Published in Radiation oncology investigations (1998)
    “…Primary spinal cord tumors are rare, and treatment recommendations are therefore difficult. We reviewed a 22-year experience of postoperative radiotherapy for…”
    Get more information
    Journal Article
  4. 4

    Hypnosis in palliative care by Gamus, Dorit, Kedar, Amos, Kleinhauz, Moris

    Published in Progress in palliative care (01-11-2012)
    “…The aim of this article is to review studies on the effect of mind-body therapies, and specifically that of hypnotherapy in palliative care and to asses its…”
    Get full text
    Journal Article
  5. 5

    A new point mutation in a hypoxanthine phosphoribosyltransferase-deficient patient by HIDALGO-LAOS, R. I, KEDAR, A, WILLIAMS, C. A, NEIBERGER, R. E

    Published in Pediatric nephrology (Berlin, West) (01-10-1997)
    “…A 12-year-old boy was referred because of abdominal pain, gross hematuria, and passage of stones. Further evaluation showed growth delay, low average range of…”
    Get full text
    Conference Proceeding Journal Article
  6. 6

    Unrelated cord blood transplantation in children with sickle cell disease: Review of four-center experience by Adamkiewicz, Tom V., Szabolcs, Paul, Haight, Ann, Baker, K. Scott, Staba, Susan, Kedar, Amos, Chiang, K. Y., Krishnamurti, Lakshmanan, Boyer, Michael W., Kurtzberg, Joan, Wagner, John E., Wingard, John R., Yeager, Andrew M.

    Published in Pediatric transplantation (01-09-2007)
    “…:  UCBT was performed in seven children with SCD and stroke (HLA match 4/6 n = 5; 5/6 n = 2). Four received myeloablative regimens (BU, CY, ATG plus FLU in one…”
    Get full text
    Journal Article
  7. 7

    Response of osteogenic sarcoma to the combination of etoposide and cyclophosphamide as neoadjuvant chemotherapy by Saleh, R A, Graham-Pole, J, Cassano, W, Abbot, F, Vander Griend, R, Dickson, N, Metha, P, Heare, M, Kedar, A, Heare, T

    Published in Cancer (15-02-1990)
    “…A Phase II study of the combination of etoposide (VP-16) and cyclophosphamide (CPM) was conducted in an attempt to identify active and potentially less toxic…”
    Get more information
    Journal Article
  8. 8

    Value of thallium-201 SPECT imaging in childhood brain tumors by Maria, B L, Drane, W E, Quisling, R G, Ringdahl, D M, Mickle, J P, Mendenhall, N P, Marcus, Jr, R B, McCollough, W M, Hamed, L M, Eskin, T A

    Published in Pediatric neurosurgery (1994)
    “…Thallium-201 chloride single photon emission computed tomography (201Tl SPECT) has been proposed as a diagnostic tool in the assessment of patients with brain…”
    Get more information
    Journal Article
  9. 9

    RheothRx (Poloxamer 188) injection for the acute painful episode of sickle cell disease: A pilot study by ADAMS-GRAVES, P, KEDAR, A, KOSHY, M, STEINBERG, M, VEITH, R, WARD, D, CRAWFORD, R, EDWARDS, S, BUSTRACK, J, EMANUELE, M

    Published in Blood (01-09-1997)
    “…RheothRx (Glaxo Wellcome Inc, Research Triangle Park, NC; poloxamer 188) Injection is a nonionic surfactant with hemorrheologic properties that suggest it may…”
    Get full text
    Journal Article
  10. 10

    Unrelated Cord Blood Transplantation (UCBT) in Children with Sickle Cell Disease (SCD): US Centers Experience by Adamkiewicz, Tom V., Haight, Ann, Mazur, Melissa A., Baker, K. Scott, Szabolcs, Paul, Kedar, Amos, Chiang, K.Y., Krishnamurti, Lakshmanan, Wagner, John E., Wingard, John R., Yeager, Andrew M.

    Published in Blood (16-11-2005)
    “…UCBT may be curative in patients (pts) with high-risk SCD. Unrelated cord blood units matched at >4/6 HLA are acceptable for UCBTs and available to most pts…”
    Get full text
    Journal Article
  11. 11

    Measurement of cerebrovascular flow reserve in pediatric patients with sickle cell disease by Kedar, Amos, Drane, Walter E., Shaeffer, Douglas, Nicole, Michael, Adams, Caroline

    Published in Pediatric Blood & Cancer (01-02-2006)
    “…Purpose To report a method for determining absolute percentage change in cerebral blood flow (measurement of cerebrovascular reserve) before and after…”
    Get full text
    Journal Article
  12. 12

    Medulloblastoma: time-dose relationship based on a 30-year review by del Charco, J O, Bolek, T W, McCollough, W M, Maria, B L, Kedar, A, Braylan, R C, Mickle, J P, Buatti, J M, Mendenhall, N P, Marcus, Jr, R B

    “…Time-dose relationships have proven important in many cancer sites. This study evaluates the time factors involved in the successful postoperative radiotherapy…”
    Get more information
    Journal Article
  13. 13

    Sebastian syndrome with abnormal platelet response to ristocetin by Redman, Rachel, Shunkwiler, Sara M, Harris, Neil S, Kedar, Amos, Clapp, William L

    Published in Laboratory hematology (01-09-2008)
    “…Sebastian syndrome is characterized by enlarged platelets and Döhle-like body leukocyte inclusions. This syndrome is an MYH-9-related disease, a group that…”
    Get more information
    Journal Article
  14. 14

    Chemotherapy for pediatric brain tumors by Kedar, Amos

    Published in Seminars in pediatric neurology (01-12-1997)
    “…Advances have recently been made in the use of chemotherapy for pediatric brain tumors. Chemotherapy increases disease-free survival in high-risk primltive…”
    Get full text
    Journal Article
  15. 15

    Thalidomide in Children Undergoing Bone Marrow Transplantation: Series at a Single Institution and Review of the Literature by Mehta, Paulette, Kedar, Amos, Graham-Pole, John, Skoda-Smith, Suzanne, Wingard, John R

    Published in Pediatrics (Evanston) (01-04-1999)
    “…Thalidomide has one of the most notorious drug histories because of its teratogenicity. Its widespread use in the 1960s led to a worldwide epidemic of…”
    Get full text
    Journal Article
  16. 16

    Atrial natriuretic peptide as a marker for doxorubicin-induced cardiotoxic effects by Bauch, M, Ester, A, Kimura, B, Victorica, B E, Kedar, A, Phillips, M I

    Published in Cancer (15-03-1992)
    “…Doxorubicin is an effective antineoplastic agent, but it frequently causes dose-related cardiotoxic effects. Because the atrial natriuretic peptide (ANP) level…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Philadelphia Chromosome and Monosomy 7 in Childhood Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Study by Russo, Carolyn, Carroll, Andrew, Kohler, Sabine, Borowitz, Michael, Amylon, Michael, Homans, Alan, Kedar, Amos, Shuster, Jonathan, Land, Vita, Crist, William, Pullen, Jeanette, Link, Michael

    Published in Blood (01-03-1991)
    “…During an 8-year period, 3,638 children from institutions of the Pediatric Oncology Group (POG) were diagnosed with acute lymphoblastic leukemia (ALL)…”
    Get full text
    Journal Article
  19. 19

    LYMPHOHISTIOCYTIC ANAPLASTIC LARGE CELL LYMPHOMA STAGE I: Long-Term Survival after Resection Alone by Kedar, Amos, Braylan, Raul C.

    Published in Pediatric hematology and oncology (2000)
    “…A 17-year-old female presented with axillary lymphadenopathy, which, on biopsy, demonstrated an anaplastic large cell lymphoma of the lymphohistiocytic type…”
    Get full text
    Journal Article
  20. 20

    Clinical versus laboratory tumor lysis syndrome in children with acute leukemia by Kedar, A, Grow, W, Neiberger, R E

    Published in Pediatric hematology and oncology (1995)
    “…Renal and metabolic complications of tumor lysis syndrome (TLS) were recognized frequently in the 1960s and 1970s. Strategies were designed to prevent TLS. We…”
    Get more information
    Journal Article